During the past decade, Centro Respiratorio de México conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Respiratorio de México" #1 collaborator was "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Centro Respiratorio de México" are "Idiopathic Pulmonary Fibrosis" (3 trials), "Smoking Cessation" (2 trials), "Chronic Obstructive Pulmonary Disease" (1 trials) and "Influenza" (1 trials). Many other conditions were trialed in "Centro Respiratorio de México" in a lesser frequency.

Most popular intervention types in "Centro Respiratorio de México" are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "PRM-151 (Zinpentraxin Alfa)" (2 trials), "Baloxavir Marboxil" (1 trials), "Lebrikizumab" (1 trials) and "Nicotine Replacement Therapy Patch" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro Respiratorio de México" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Centro Respiratorio de México". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Centro Respiratorio de México, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centro Respiratorio de México, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".